Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Gabriel V Fontaine
Major Bleeding With Dabigatran and Rivaroxaban in Patients With Atrial Fibrillation
Clinical and Applied Thrombosis/Hemostasis
Medicine
Hematology
Related publications
Pharmacoeconomic Analysis of Dabigatran in Patients With Atrial Fibrillation: Comparison With Rivaroxaban or Apixaban
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Characteristics, Management, and Outcomes of Patients With Atrial Fibrillation Experiencing a Major Bleeding Event While on Rivaroxaban
Clinical and Applied Thrombosis/Hemostasis
Medicine
Hematology
Risk Factors and Prevention of Dabigatran-Related Gastrointestinal Bleeding in Patients With Atrial Fibrillation
Journal of Arrhythmia
Cardiovascular Medicine
Cardiology
How to Use Dabigatran in Patients With Atrial Fibrillation
Rational Pharmacotherapy in Cardiology
Cardiovascular Medicine
Pharmacology
Cardiology
Incidence of Major Bleeding Complication of Warfarin Therapy in Japanese Patients With Atrial Fibrillation
Circulation Journal
Medicine
Cardiovascular Medicine
Cardiology
Mild Renal Disease Increases Major Bleeding in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Stenting
Thrombosis and Haemostasis
Hematology
Prevention of Bleeding in Patients With Atrial Fibrillation Undergoing PCI
New England Journal of Medicine
Medicine
Dabigatran Versus Warfarin in Patients With Atrial Fibrillation: An Analysis of Patients Undergoing Cardioversion
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Assessing the Risk of Bleeding in Patients With Atrial Fibrillation: The Loire Valley Atrial Fibrillation Project
Circulation: Arrhythmia and Electrophysiology
Medicine
Cardiovascular Medicine
Physiology
Cardiology